-transparent.png){kind=logo}
Female CBA mice were treated weekly with subcutaneous injections of 1,2-dimethyl-hydrazine (8 mg/Kg b. w.) for 38--40 weeks. All animals but one developed tumors, mainly of the uterus, and region and intestine. Uterine tumors were most likely endometrial sarcomas, although myometrial and vascular components were also present. Large tumors of the anal region were squamous cell or baso-squamous carcinomata, while small growths were sebaceous adenomas or basal-cell tumors. 1.2-dimethylhydrazine appears to be a more multipotent carcinogen for mice than for the rat. Uterine sarcomas are of special interest in view of their rarity in mice.
Related Publications
V S Turusov, and
N S Lanko, and
L S Bazlova
January 1992,
Toxicologic pathology,
V S Turusov, and
N S Lanko, and
L S Bazlova
November 1988,
Carcinogenesis,
V S Turusov, and
N S Lanko, and
L S Bazlova
January 1978,
Voprosy onkologii,
V S Turusov, and
N S Lanko, and
L S Bazlova
June 2000,
Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie,
V S Turusov, and
N S Lanko, and
L S Bazlova
October 1983,
Biulleten' eksperimental'noi biologii i meditsiny,
V S Turusov, and
N S Lanko, and
L S Bazlova
May 1979,
Biulleten' eksperimental'noi biologii i meditsiny,
V S Turusov, and
N S Lanko, and
L S Bazlova
January 1969,
Zeitschrift fur die gesamte experimentelle Medizin einschliesslich experimentelle Chirurgie,
V S Turusov, and
N S Lanko, and
L S Bazlova
September 1995,
Biulleten' eksperimental'noi biologii i meditsiny,
V S Turusov, and
N S Lanko, and
L S Bazlova
September 1995,
Clinical & experimental metastasis,
V S Turusov, and
N S Lanko, and
L S Bazlova
January 1994,
Toxicologic pathology,
